Helen Alison Frank

Title: Helen Alison Frank: Innovator in Antibody Therapeutics

Introduction

Helen Alison Frank is a prominent inventor based in Sharon, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 2 patents, her work has the potential to impact therapeutic and diagnostic methods in medicine.

Latest Patents

Helen's latest patents include innovative anti-GCC antibody molecules and methods for their use. These patents disclose antibodies and antigen-binding fragments that specifically bind to GCC. The inventions also provide therapeutic and diagnostic methods utilizing these antibodies and their fragments, showcasing her commitment to advancing medical science.

Career Highlights

Helen has established herself as a key figure in the biotechnology sector. She is currently associated with Millennium Pharmaceuticals Limited, where she continues to work on groundbreaking research and development projects. Her expertise in antibody technology has positioned her as a valuable asset in her field.

Collaborations

Helen has collaborated with notable colleagues, including Theresa O'Keefe and Alice McDonald. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Helen Alison Frank's contributions to antibody therapeutics exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts highlight her role as a leading inventor in the biotechnology industry.